Fluid and vasopressor therapy in sepsis

被引:0
|
作者
Petros, Sirak [1 ]
机构
[1] Univ Klinikum Leipzig, Interdisziplinare Internist Intens Med, Liebigstr 20, D-04103 Leipzig, Germany
关键词
Septic shock; Hemodynamics; Fluid therapy; Vasoconstrictor agents; Cardiotonic agents; SEPTIC SHOCK; NOREPINEPHRINE; DYSFUNCTION; SURVIVAL; RISK;
D O I
10.1007/s00063-022-00976-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is one of the most common and lethal conditions in intensive care medicine. Besides adequate treatment of the infection, timely hemodynamic management is essential to treat tissue hypoperfusion due to sepsis. Adequate fluid resuscitation plays a central role, and this should be carried out with dynamic monitoring of the hemodynamic response. However, a positive fluid balance is associated with poor outcome. Vasopressor therapy is required in case of inadequate response to fluid resuscitation, with norepinephrine considered the first choice. With increasing norepinephrine dose, addition of hydrocortisone or vasopressin may contribute to maintaining the hemodynamic state, although the prognostic advantage of these drugs has not been demonstrated. While dobutamine may be considered in patients with septic cardiomyopathy, the evidence for inotropic therapy in sepsis is limited.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [1] Volumen- und vasoaktive Therapie bei SepsisFluid and vasopressor therapy in sepsis
    Sirak Petros
    Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2023, 118 (2) : 163 - 171
  • [2] The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients
    Lat, Ishaq
    Coopersmith, Craig M.
    De Backer, Daniel
    CRITICAL CARE MEDICINE, 2021, 49 (04) : 623 - 635
  • [3] The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients
    Lat, Ishaq
    Coopersmith, Craig M.
    De Backer, Daniel
    INTENSIVE CARE MEDICINE EXPERIMENTAL, 2021, 9 (01)
  • [4] The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients
    Ishaq Lat
    Craig M. Coopersmith
    Daniel De Backer
    Craig M. Coopersmith
    Intensive Care Medicine Experimental, 9
  • [5] Vasopressor Therapy
    Vincent, Jean-Louis
    Annoni, Filippo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [6] Fluid Therapy in Dogs and Cats With Sepsis
    Montealegre, Federico
    Lyons, Bridget M.
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [7] A rational approach to fluid therapy in sepsis
    Marik, P.
    Bellomo, R.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (03) : 339 - 349
  • [8] SYSTEMIC HEMODYNAMIC ABNORMALITIES AND VASOPRESSOR THERAPY IN SEPSIS AND SEPTIC SHOCK
    QUEZADO, ZMN
    NATANSON, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (03) : 214 - 222
  • [9] Vasopressor administration and sepsis: A survey of Canadian intensivists
    Lamontagne, Francois
    Cook, Deborah J.
    Adhikari, Neill K. J.
    Briel, Matthias
    Duffett, Mark
    Kho, Michelle E.
    Burns, Karen E. A.
    Guyatt, Gordon
    Turgeon, Alexis F.
    Zhou, Qi
    Meade, Maureen O.
    JOURNAL OF CRITICAL CARE, 2011, 26 (05) : 532.e1 - 532.e7
  • [10] Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function
    Correa, Thiago Domingos
    Vuda, Madhusudanarao
    Takala, Jukka
    Djafarzadeh, Siamak
    Silva, Eliezer
    Jakob, Stephan Mathias
    CRITICAL CARE, 2013, 17 (01)